0000000000267911

AUTHOR

Philipp Kämmerer

showing 3 related works from this author

Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma.

2010

Glutathione S-transferases (GST) are antioxidant enzymes and oxidative stress markers in oral carcinogenesis. They present a system of polymorphic proteins. Some variants are associated with increased sensitivity to toxic compounds, as it is known for the GSTM1-null variant allele. However, the influence of the GSTM1 allele variant genotype on GSTM1-mRNA quantity in oral squamous cell carcinoma (OSCC) and normal mucosa as well as the impact on prognosis remains unclear. The genotype for GSTM1 (mutation vs. wild type) was determined by polymerase chain reaction (PCR) using genomic DNA extracted from peripheral blood from 28 OSCC patients. From the same patients, 28 pairs of OSCC cells and no…

MaleCancer ResearchPathologymedicine.medical_specialtyGenotypemedicine.disease_causeGenotypeGene expressionmedicineCarcinomaBiomarkers TumorHumansAlleleneoplasmsAgedGlutathione TransferaseNeoplasm StagingRegulation of gene expressionPolymorphism Geneticintegumentary systembiologyWild typeMouth Mucosamedicine.diseaseMolecular biologyTumor BurdenGene Expression Regulation NeoplasticGlutathione S-transferaseOncologyLymphatic Metastasisbiology.proteinCarcinoma Squamous CellFemaleMouth NeoplasmsOral SurgeryCarcinogenesisOral oncology
researchProduct

Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma

2010

J Oral Pathol Med (2010) 39: 786–792 Background:  Vascular endothelial growth factor (VEGF) plays an important role in promoting angiogenesis and is overexpressed in several malignancies. Polymorphisms of the VEGF gene can alter VEGF protein expression, which may be biologically significant and account for heterogeneity in disease risk and outcome. The aim of this case–control study was to evaluate potential associations between single nucleotide polymorphisms (SNP) of the VEGF gene with susceptibility of oral squamous cell carcinoma (OSCC). Patients and methods:  Five VEGF SNP (−1154 G/A, +405 G/C, +936 C/T, −2578 C/A and −460 C/T) were determined in peripheral blood isolated from 80 patie…

Mouth neoplasmCancer ResearchPathologymedicine.medical_specialtyAngiogenesisSingle-nucleotide polymorphismBiologyPathology and Forensic MedicineVascular endothelial growth factorstomatognathic diseaseschemistry.chemical_compoundVascular endothelial growth factor AOtorhinolaryngologychemistrymedicineCancer researchPeriodonticsBiomarker (medicine)SNPOral SurgeryAlleleJournal of Oral Pathology & Medicine
researchProduct

Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma

2010

Costimulatory molecules have complementary effects on T-cell activation and their balance may control the development of oral cancer. The aim of this study was to determine the relevance of cytotoxic T-lymphocyte antigen 4 (CTLA-4), CD28 and inducible costimulator (ICOS) polymorphisms in oral squamous cell carcinoma (OSCC). Genotyping for CTLA-4 (-1661 A/G and +49 A/G), CD28 (0 C/G and +3160 G/T) and ICOS (+637 A/C and +1599 C/T) was performed in the 83 patients with OSCC, compared to the 40 unrelated healthy volunteers as controls. The genotype CTLA-4 -1661 was significantly different between the patient group and the control group. The allele CTLA-4 -1661 G was significantly found more fr…

AdultMaleCancer ResearchT cellchemical and pharmacologic phenomenaLymphocyte ActivationT-Lymphocytes RegulatoryAntigenAntigens CDGenotypemedicineHumansCytotoxic T cellCTLA-4 AntigenGenetic Predisposition to DiseaseProspective StudiesAgedAged 80 and overMouth neoplasmPolymorphism Geneticbusiness.industryCD28hemic and immune systemsT lymphocyteMiddle AgedMolecular biologystomatognathic diseasesmedicine.anatomical_structureOncologyCTLA-4Case-Control StudiesImmunologyCarcinoma Squamous CellFemaleMouth NeoplasmsOral SurgerybusinessT-Lymphocytes CytotoxicOral Oncology
researchProduct